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EDITORIAL
Of laminins and delamination in Alport syndrome
Alport syndrome is a genetic disease of the glomerular of the laminin 2 and 1 chains in the GBM occurs both
basement membrane (GBM) leading to a delayed-onset, in human Alport syndrome and in animal models of
progressive nephritis. Alport syndrome is caused by mu- Alport syndrome [5–7]. In addition, we found ectopic
tation in any one of the three genes encoding the type IV accumulation of laminin 1 in mouse Alport GBM [6].
collagen 3, 4, and 5 chains, COL4A3, COL4A4, and Normally, laminin-11 (521) is the only known lami-
COL4A5, respectively. These three chains form the ma- nin trimer present in the mature GBM [8]. Accumulation
jor collagen IV network that is present in the GBM. Most of the laminin 2, 1, and 1 chains could be pathogenic,
mutations that cause Alport syndrome result in the ab- perhaps leading to the typical lesions observed in Alport
sence of all three of these collagen IV chains, presumably GBM and/or to aberrant behavior of the adjacent podo-
because their assembly into the GBM requires the pres- cytes and subsequent foot process effacement and pro-
ence of all three chains [1, 2]. teinuria. Expression of laminins 1 and 1 is particularly
Alport GBM is able to function normally early in life interesting because these two chains are found in devel-
because the collagen 1 and 2(IV) chains substitute for oping GBM, but they are normally eliminated at matu-
the missing3-5(IV) chains. However, there is a progres- rity; 1 is replaced by 5 and 1 is replaced by 2 [9].
sive thickening and splitting of Alport GBM that is asso- In this issue of Kidney International, Abrahamson et al
ciated with the onset of hematuria and eventual glomerular [10] present a detailed analysis of laminin 1 and 1 depo-
obsolescence. Why these very characteristic ultrastruc- sition in the GBMs of a mouse model of Alport syndrome
tural GBM abnormalities occur is an important question harboring a Col4a3 mutation. In addition to confirming
with regard to onset and progression of the disease. the finding that laminins1 and1 are deposited in Alport
Three major theories have emerged. First, intrinsic prop- GBM, they show that in still developing kidneys, laminin
erties of the collagen 1/2(IV) network in Alport GBM 1 is eliminated on schedule at the capillary loop stage
makes the GBM less structurally sound and more suscep- of glomerulogenesis, but it reappears in the mature GBM
tible to mechanical strain caused by the pressure of ultra- very soon thereafter. The sites of reappearance are those
filtration. Second, the collagen 1/2(IV) network is areas of GBM that exhibit the subepithelial thickening
more susceptible to proteolysis by endogenous proteases and delamination that is characteristic of Alport GBM.
than is the normal 345(IV) network [3]. Third, re- The authors elegantly show by immunoelectron micros-
placement of the normal collagen IV network with the copy that both podocytes and endothelial cells contribute
1/2(IV) network results in aberrant accumulation of laminin 1 to the affected GBM. Interestingly, no 1 or
noncollagenous extracellular matrix molecules, leading 1 was detected in ultrastructurally normal stretches of
eventually to a disrupted ultrastructure. GBM, demonstrating a clear association between GBM
In support of the first two theories, the collagen 3 lesions and deposition of ectopic laminins.
and 4(IV) chains contain significantly more cysteines Like all provocative findings, these lead to additional
than do the 1 and 2(IV) chains, so more extensive important questions that will hopefully be answered by
disulphide cross-linking, both within and between tri- future studies. First, do the GBM lesions elicit synthesis
mers, should occur [4]. This would be expected to impart of the ectopic laminins by the adjacent glomerular cells,
increased mechanical stability to the collagen IV net- or does the aberrant type IV collagen complement pres-
work and perhaps also resistance to proteases. Indeed, ent in Alport GBM elicit deposition of ectopic laminins,
in vitro studies showed that a bulk basement membrane which then results in the observed lesions? If the latter
preparation from an Alport syndrome kidney was more is correct, then preventing ectopic expression of the lami-
susceptible to protease degradation than was a similar nin 1, 1, and 2 chains will perhaps improve GBM
preparation from a normal kidney [3]. However, whether ultrastructure and slow disease progression. In fact, mu-
this reflects the in vivo situation with respect to the GBM tation of integrin 1 in the same mouse model of Alportremains to be determined. syndrome inhibited both accumulation of ectopic lami-
In support of the third theory, ectopic accumulation nins (2 and 1) and GBM delamination, and this was
associated with slowed progression to renal failure [5].
(Whether 1 deposition was affected in this context wasKey words: laminin, basement membrane, collagen IV, glomerulo-
nephritis. not studied.) Second, are the ectopic laminins themselves
pathogenic, or are the GBM lesions alone sufficiently 2003 by the International Society of Nephrology
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